The value of thrombus markers applied in patients with respiratory failure
Background: This work assessed the value of novel thrombus markers-thrombin-antithrombin complex (TAT), plasmin-a2-plasmin inhibitor complex (PIC), thrombomodulin (TM), and tissue plasminogen activator-inhibitor complex (t-PAIC) applied in patients with respiratory failure (RF), including their role...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Society of Medical Biochemists of Serbia, Belgrade
2025-01-01
|
| Series: | Journal of Medical Biochemistry |
| Subjects: | |
| Online Access: | https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2025/1452-82582501031C.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832096578808053760 |
|---|---|
| author | Yingqun Chen Zihan Yin Junshi Wang Cunliang Yan Xuwei Lin Lei Huang |
| author_facet | Yingqun Chen Zihan Yin Junshi Wang Cunliang Yan Xuwei Lin Lei Huang |
| author_sort | Yingqun Chen |
| collection | DOAJ |
| description | Background: This work assessed the value of novel thrombus markers-thrombin-antithrombin complex (TAT), plasmin-a2-plasmin inhibitor complex (PIC), thrombomodulin (TM), and tissue plasminogen activator-inhibitor complex (t-PAIC) applied in patients with respiratory failure (RF), including their role in predicting thrombus formation, evaluating prognosis, and assessing disease severity. Methods: Eighty patients with RF were enrolled and categorized into mild (n = 10), moderate (n = 9), and severe (n = 71) groups based on disease severity. Meanwhile, patients were also classified into thrombus (n = 14) and non-thrombus (n = 76) groups based on the presence of thrombus. Furthermore, they were assigned into survival (n = 70) and death (n = 20) groups based on prognosis. Traditional coagulation indicators, thrombus markers, infection-related parameters, and respiratory-related indicators were compared among patients in different groups. This work explored the predictive effects of these indicators on the degree of respiratory failure, thrombus formation, and prognosis in various patient groups. Additionally, correlations of thrombus markers and traditional coagulation indicators to respiratory-related indicators and infectionrelated indicators were analyzed. Results: Upon admission, levels of thrombin-antithrombin complex (TAT), plasmin-a2-plasmin inhibitor complex (PIC), and tissue plasminogen activator-inhibitor complex (t-PAIC) in the thrombus group were sharply higher in contrast to those in the non-thrombus group, showing obvious differences (P<0.05). Patients in the death group experienced remarkably elevated TAT, PIC, t-PAIC, thrombomodulin (TM), and to the survival group (P<0.05). In addition, high-sensitivity C-reactive protein (hs-CRP) in the death group was higher to that in the survival group (P<0.05). Platelet count (PLT) and procalcitonin (PCT) were sharply lower in the survival group (P<0.05). In groups of varying severity, PCT exhibited an elevated level in the severe, demonstrating great differences to the mild to moderate groups (P<0.05). Besides, TAT, PIC, TM, and t-PAIC showed higher sensitivity and accuracy in predicting severe RF, with higher specificity in predicting thrombus formation in RF patients. In correlation analysis, a positive correlation was observed between TT, PCT, and the fraction of inspired oxygen (FiO2). The activated partial thromboplastin time (APTT), PCT, and FiO2 exhibited positive correlations. Additionally, a positive association existed between fibrinogen (FIB), hs-CRP, and PLT. A positive link was identified between D-dimer and hs-CRP, PIC and PLT, as well as tPAIC and PCT. Conclusions: Thrombus markers exerted a crucial effect in patients experiencing respiratory failure, serving as pivotal indicators for assessing the severity of the condition, identifying thrombotic risk, and predicting prognosis. |
| format | Article |
| id | doaj-art-468eaad33f2f496dbc220607cbf3f437 |
| institution | Kabale University |
| issn | 1452-8258 1452-8266 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Society of Medical Biochemists of Serbia, Belgrade |
| record_format | Article |
| series | Journal of Medical Biochemistry |
| spelling | doaj-art-468eaad33f2f496dbc220607cbf3f4372025-02-05T13:11:23ZengSociety of Medical Biochemists of Serbia, BelgradeJournal of Medical Biochemistry1452-82581452-82662025-01-01441314510.5937/jomb0-506971452-82582501031CThe value of thrombus markers applied in patients with respiratory failureYingqun Chen0Zihan Yin1Junshi Wang2Cunliang Yan3Xuwei Lin4Lei Huang5Peking University Shenzhen Hospital, Department of Critical Care Medicine, Shenzhen, ChinaPeking University Shenzhen Hospital, Department of Critical Care Medicine, Shenzhen, ChinaPeking University Shenzhen Hospital, Department of Critical Care Medicine, Shenzhen, ChinaPeking University Shenzhen Hospital, Department of Clinical Laboratory, Shenzhen, ChinaPeking University Shenzhen Hospital, Department of Critical Care Medicine, Shenzhen, ChinaPeking University Shenzhen Hospital, Department of Critical Care Medicine, Shenzhen, ChinaBackground: This work assessed the value of novel thrombus markers-thrombin-antithrombin complex (TAT), plasmin-a2-plasmin inhibitor complex (PIC), thrombomodulin (TM), and tissue plasminogen activator-inhibitor complex (t-PAIC) applied in patients with respiratory failure (RF), including their role in predicting thrombus formation, evaluating prognosis, and assessing disease severity. Methods: Eighty patients with RF were enrolled and categorized into mild (n = 10), moderate (n = 9), and severe (n = 71) groups based on disease severity. Meanwhile, patients were also classified into thrombus (n = 14) and non-thrombus (n = 76) groups based on the presence of thrombus. Furthermore, they were assigned into survival (n = 70) and death (n = 20) groups based on prognosis. Traditional coagulation indicators, thrombus markers, infection-related parameters, and respiratory-related indicators were compared among patients in different groups. This work explored the predictive effects of these indicators on the degree of respiratory failure, thrombus formation, and prognosis in various patient groups. Additionally, correlations of thrombus markers and traditional coagulation indicators to respiratory-related indicators and infectionrelated indicators were analyzed. Results: Upon admission, levels of thrombin-antithrombin complex (TAT), plasmin-a2-plasmin inhibitor complex (PIC), and tissue plasminogen activator-inhibitor complex (t-PAIC) in the thrombus group were sharply higher in contrast to those in the non-thrombus group, showing obvious differences (P<0.05). Patients in the death group experienced remarkably elevated TAT, PIC, t-PAIC, thrombomodulin (TM), and to the survival group (P<0.05). In addition, high-sensitivity C-reactive protein (hs-CRP) in the death group was higher to that in the survival group (P<0.05). Platelet count (PLT) and procalcitonin (PCT) were sharply lower in the survival group (P<0.05). In groups of varying severity, PCT exhibited an elevated level in the severe, demonstrating great differences to the mild to moderate groups (P<0.05). Besides, TAT, PIC, TM, and t-PAIC showed higher sensitivity and accuracy in predicting severe RF, with higher specificity in predicting thrombus formation in RF patients. In correlation analysis, a positive correlation was observed between TT, PCT, and the fraction of inspired oxygen (FiO2). The activated partial thromboplastin time (APTT), PCT, and FiO2 exhibited positive correlations. Additionally, a positive association existed between fibrinogen (FIB), hs-CRP, and PLT. A positive link was identified between D-dimer and hs-CRP, PIC and PLT, as well as tPAIC and PCT. Conclusions: Thrombus markers exerted a crucial effect in patients experiencing respiratory failure, serving as pivotal indicators for assessing the severity of the condition, identifying thrombotic risk, and predicting prognosis.https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2025/1452-82582501031C.pdfthrombus markersrespiratory failurethrombus formationprognosisdisease severity |
| spellingShingle | Yingqun Chen Zihan Yin Junshi Wang Cunliang Yan Xuwei Lin Lei Huang The value of thrombus markers applied in patients with respiratory failure Journal of Medical Biochemistry thrombus markers respiratory failure thrombus formation prognosis disease severity |
| title | The value of thrombus markers applied in patients with respiratory failure |
| title_full | The value of thrombus markers applied in patients with respiratory failure |
| title_fullStr | The value of thrombus markers applied in patients with respiratory failure |
| title_full_unstemmed | The value of thrombus markers applied in patients with respiratory failure |
| title_short | The value of thrombus markers applied in patients with respiratory failure |
| title_sort | value of thrombus markers applied in patients with respiratory failure |
| topic | thrombus markers respiratory failure thrombus formation prognosis disease severity |
| url | https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2025/1452-82582501031C.pdf |
| work_keys_str_mv | AT yingqunchen thevalueofthrombusmarkersappliedinpatientswithrespiratoryfailure AT zihanyin thevalueofthrombusmarkersappliedinpatientswithrespiratoryfailure AT junshiwang thevalueofthrombusmarkersappliedinpatientswithrespiratoryfailure AT cunliangyan thevalueofthrombusmarkersappliedinpatientswithrespiratoryfailure AT xuweilin thevalueofthrombusmarkersappliedinpatientswithrespiratoryfailure AT leihuang thevalueofthrombusmarkersappliedinpatientswithrespiratoryfailure AT yingqunchen valueofthrombusmarkersappliedinpatientswithrespiratoryfailure AT zihanyin valueofthrombusmarkersappliedinpatientswithrespiratoryfailure AT junshiwang valueofthrombusmarkersappliedinpatientswithrespiratoryfailure AT cunliangyan valueofthrombusmarkersappliedinpatientswithrespiratoryfailure AT xuweilin valueofthrombusmarkersappliedinpatientswithrespiratoryfailure AT leihuang valueofthrombusmarkersappliedinpatientswithrespiratoryfailure |